Clinical trial
A Phase I Study of the Safety and Immunogenicity of MVA85A in Healthy Gambian…
NCT00423839 · University of Oxford, Other · Completed
Key facts
| NCT number | NCT00423839 |
|---|---|
| Title | A Phase I Study of the Safety and Immunogenicity of MVA85A in Healthy Gambian Volunteers |
| Official title | A Phase I Study of the Safety and Immunogenicity of MVA85A in Healthy Gambian Volunteers |
| Lead sponsor | University of Oxford, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Tuberculosis |
| Intervention type | Biological |
| Interventions | MVA85A (Tuberculosis vaccine) |
| Enrollment | 12 |
| Start date | Mar 1, 2003 |
| Completion | Jul 1, 2005 |
| First posted | Jan 18, 2007 |
| Last update posted | Jan 18, 2007 |
| Countries | The Gambia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: